The CSIRO has declared that artificial intelligence is no longer a background tool in Australian medicine but a central force shaping how patients are diagnosed and treated, in a report released on 30 June by its Australian e-Health Research Centre in Brisbane.
The report, AI Trends for Healthcare 2026, argues that the arrival of generative AI has dragged the technology out of the server room and into the clinic. Where AI once ran quietly behind medical imaging and administration, it now sits close to decisions that affect patient care.
“For many years, AI has largely been ‘under the hood’ – a powerful but often invisible technology understood mostly by technical experts,” said Dr David Hansen, chief executive and research director of the Australian e-Health Research Centre (AEHRC). He said the rapid rise of generative AI had changed that, while sharpening the focus on safety, quality and responsible use.
From research project to clinical product
The report’s central message, as trade outlet The Medical Republic framed it, is that healthcare AI has grown up. Tools that were once research experiments are now regulated clinical products, and the hardest part is no longer building the model but getting it approved and keeping it safe.
Many AI applications intended for clinical use fall within Australia’s Software as a Medical Device (SaMD) framework. That means regulatory strategy, quality management and Therapeutic Goods Administration approval become critical from the outset, not afterthoughts bolted on before launch.
The AEHRC points to its own experience as a template. As Pulse+IT reported, the centre has completed Medical Device Single Audit Program certification, allowing submissions to the TGA in Australia as well as the United States Food and Drug Administration and Health Canada. The report urges developers to treat quality management as a continuous discipline rather than a box ticked before a conformity assessment.
The document sits in a line of annual CSIRO healthcare AI reports stretching back to 2024, when the agency first described an “extraordinary era” for the technology. This year’s edition reflects how quickly the ground has shifted since generative tools became mainstream.
What AI is already doing in Australian hospitals
The report is grounded in concrete clinical use rather than speculation. It highlights AI generating synthetic CT scans from MRI images, helping clinicians plan radiotherapy more accurately while reducing a patient’s exposure to radiation.
Other current applications span clinical decision support, medical imaging analysis, disease management and personalised care. The The Australia Today reported that the rapid expansion of electronic medical records across Australian hospitals has given these tools the digitised data they need, and named medical research, aged care and disability support as areas set to benefit.
Dr Hansen has been blunt about why the stakes differ from other industries. He told The Australia Today that in healthcare “the accuracy of models could mean the difference between life and death, or ongoing health and illness”. He added that established safety, quality and monitoring guidelines “continue to be imperative”.
The report also looks ahead to multimodal AI, which combines images, text and other data types, and to AI-assisted software development, flagging them as innovations likely to shape the next wave of healthcare tools.
The unfinished work: standards, data and trust
The CSIRO is candid that the technology is running ahead of the guardrails. It identifies four areas that must be addressed for AI to be safe and effective at scale: regulation, quality management, data governance and digital health interoperability.
Interoperability is the plumbing that lets systems share data reliably, and the report backs national efforts such as Sparked, Australia’s accelerator for the Fast Healthcare Interoperability Resources (FHIR) standard, to make sure AI tools can slot into existing systems.
Data governance is a recurring theme. Dr Hansen argued that AI could help rather than hinder patient control, saying the technology “can play an important role in allowing Australians to have full access to and control over their health data”, according to The Australia Today.
The Hospital + Healthcare coverage stressed the report’s call for ethical implementation frameworks alongside safety and quality monitoring, particularly as the volume of health data grows and privacy concerns mount.
Why it matters for Australia
For a health system under sustained pressure from an ageing population and workforce shortages, AI is being pitched as a way to ease the load on clinicians and lift efficiency. The CSIRO’s message is that Australia is no longer trialling the technology at the margins; it is embedding it in day-to-day care.
There is a sovereignty dimension too. The report’s emphasis on locally developed, TGA-ready tools and Australian-led standards such as Sparked reflects a push to build home-grown capability rather than depend wholly on overseas products for something as sensitive as clinical care.
The report also carries a skills warning between the lines. Hospitals, regulators and vendors will need people who understand both medicine and machine learning, and who can manage quality systems over a product’s whole life. That demand for regulatory, data-governance and interoperability expertise points to a widening set of jobs the country will need to fill.
Dr Hansen stressed that the answer is collaboration, not automation for its own sake. New AI technologies, he said, “need to be developed hand-in-hand with clinicians and industry”, with community co-designed standards underpinning them.
What comes next
The immediate test is whether Australia can turn the report’s recommendations into settled national standards before adoption outpaces oversight. Work on FHIR standards through Sparked, clearer TGA pathways for Software as a Medical Device, and shared quality frameworks will shape how fast and how safely the next tools reach patients.
The CSIRO’s annual cadence means a 2027 edition will effectively mark its own homework. On this year’s evidence, the technology has already moved to the centre of the room; the question now is whether the rules can keep pace.
Sources: CSIRO, The Medical Republic, Pulse+IT, The Australia Today, Hospital + Healthcare.
